Cytodyn Inc (CYDY)

[Saltz]

IMO the reason why the stock is at this level is because there has been zero news to turn it around.

-no PR that the last private raise has been completed - that translates to silence from Nader and company which means:
-no word regarding face to face with FDA which strongly impacts Adjunct PIII completion date
-no idea where we are with enrollment with Adjunct PIII which dictates the completion date

That adds up to uncertainty for investors in the near term. The long term fundamentals have not changed, however the timeline to achieve milestones that solidify this investment is unknown. My point is the above leads to shorting. Shorting will be the Long investors best friend when the news displaces the uncertainty. Having said that all of the above will IMO be addressed shortly and and positively which will wipsaw the SP dramatically.

From a macro view all we need to know as investors is when the Adjunct PIII will be completed because the results are going to lay the foundation for a partnership and the monetizing of PRO-140. This is the most logical path to an organic up list. My gut feeling is that the focus is on how the company can best achieve this economically and in the least amount of time. Clearly a defining space in time for Cytodyn and those invested.

FYI- I do not post often because my opinions matter little in the outcome of what happens with Cytodyn. I do post occasionally because I understand the emotional roller coaster this type of investment can impart on anyone and that includes myself. This board is unique in that it is respectful, knowledgeable, and a common ground to share opinions - thanks to all that contribute. The future is bright!